Hi-Risk/Recurrent/Advanced PCa Video Chat, Aug 1, 2022

AnCan APOLOGIZES FOR ANY INCONVENIENCE FROM DOWNTIME ON OUR WEBSITE AT THE END OF JULY. AS A RESULT WE ARE NOW SWITCHING THE HOST.

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/     Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Editor’s Pick: Crossing international borders when you’re ‘hot’; and watch your statins on Nubeqa (rd)

Topics Discussed

Recurrence after 19 years???; crossing the Border on Pluvicto; delayed PSA response to Pluvicto; throat side -effects; drug holiay approved; reduced darolutamide dosage; statins and darolutamide; debating Provenge – abscopal effect with spot RT; overreading G68 PSMA scans; chemo must precede Pluvicto; why hot flashes persist with no LHRH; adding abi to adjuvant RT; treating PCa testicular spread; FMI report reveals TP53; dealing with chemo

Chat Log

Frank Fabish – Columbus OH (to Organizer(s) Only): 5:16 PM: No update from me tonight. My next checkup and blood draw is Tuesday 8/23. Leaving for Cabo San Lucas on 8/4 for two weeks. A little bit of beach therapy.

Peter Kafka – Maui (to Everyone): 5:27 PM: Is this really advanced disease? Or even recurrent yet?

Bill Franklin – Sunny Florida (to Everyone): 5:28 PM: When all you have is a hammer…

C Huerta (to Everyone): 5:58 PM: Got to get to a Board Meeting. Next time …

AnCan – rick (to Everyone): 5:58 PM: Carl you have to tell me that upfront

john antonucci–CT (to Everyone): 5:59 PM: Lu177 half life 6.7 d. decays to stable hafnium 177 via beta radiation

Ken (to Everyone): 6:01 PM: thanks John

Jim Marshall, Alexandria, VA (to Everyone): 6:06 PM: John, ask him if he is on Medicare Advantage,Part C or Medicare, Part B. The Advantage provider may be the one denying. Jim

Stephen Saft (to Everyone): 6:28 PM: From google Adverse Reactions: The most common adverse reactions reported in clinical trials (≥ 15% of patients receiving PROVENGE) were chills, fatigue, fever, back pain, nausea, joint ache, and headache.

GEORGE ROVDER Arlington VA (to Everyone): 6:28 PM: Thanks

Steve. Peter Kafka – Maui (to Everyone): 6:35 PM: Gotta go = see y’all next week.

Frank Fabish – Columbus OH (to Everyone): 6:54 PM: Gotta go guys. Thanks for the info.

Stephen Saft (to Everyone): 7:04 PM: I am going to say goodnight. Tommorrow is 3 weeks since surgery. I need some time to prepare to get bed. Thanks everyone for sharing.

Jerry Pelfrey – Mexico (to Everyone): 7:10 PM: Time, have to go now. Thanks to everyone.

David Muslin (to Everyone): 7:14 PM: Dr Russell Szmulewitz New nurse January 2022 – Meghan Catenacci meghan.catenacci@uchospitals.edu

Julian Morales – Houston (to Everyone): 7:17 PM: Have to leave. Thanks for the great advice and c onversation! See y’all next Tuesday.

Stan Friedman – Stamford (to Everyone): 7:20 PM: Good night guys. Have an early morning start.

GEORGE ROVDER Arlington VA (to Everyone): 7:33 PM: Embr Wave

Bob G. Philadelphia (to Everyone): 7:34 PM: Thanks everyone. Have a good night